We federate a European consortium of the key intense neutron sources, isotope mass separation facilities and high-power accelerators and cyclotrons, with leading biomedical and healthcare research institutes in the active translation of the emerging radionuclides into medical diagnosis and treatment.
Company Details
- Employees
- 2
- Founded
- -
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://www.prismap.eu
- Competitors
- Accelerate.EU, Nuclear Medicine Europe, British Nuclear Medicine Society, Clarity Pharmaceuticals, Nucleus RadioPharma, Ratio Therapeutics, International Atomic Energy Agency (IAEA), The Canadian Association of Nuclear Medicine - CANM, ILL - Institut Laue Langevin, ESRR - European Symposium on Radiopharmacy and Radiopharmaceuticals.
Prismap Project Questions
Prismap Project's website is https://www.prismap.eu
Prismap Project's LinkedIn profile is https://www.linkedin.com/company/prismap
Prismap Project has
2 employees.
View email and phone details for 2
employees at Prismap Project.
Prismap Project's industry is
Research Services
Prismap Project's top competitors are
Accelerate.eu,
Nuclear Medicine Europe,
British Nuclear Medicine Society,
Clarity Pharmaceuticals,
Nucleus Radiopharma,
Ratio Therapeutics,
International Atomic Energy Agency (Iaea),
The Canadian Association Of Nuclear Medicine - Canm,
Ill - Institut Laue Langevin,
Esrr - European Symposium On Radiopharmacy And Radiopharmaceuticals.
Prismap Project's categories are Research Services
Prismap Project's founding year is 2021
